Subscribe today to receive notice of our latest thought leadership, articles, and updates.
Insights
Open conversations, knowledge sharing, and fresh ideas promote positive change and transparency
Our latest updates, articles and podcasts
Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.
|
June 20, 2024 · Public Policy & Regulatory Affairs Team
The California DWC now invites further comments to yet more proposed changes to its already proposed changes to the state’s workers’ comp pharmacy fee schedule rules. Rely on Optum to make sense of it all. Read more... |
|
June 12, 2024 · Public Policy & Regulatory Affairs Team
Read more... |
|
June 01, 2024 · Published by WorkCompWire
June is National PTSD Awareness Month. And when it comes to PTSD laws covering workers’ comp, no two states are the same. The Optum Public Policy & Regulatory Affairs (PPRA) team helps claims professionals understand the laws and regulations for their state. Read more... |
|
May 29, 2024 · Public Policy & Regulatory Affairs Team
Robert Wilson, president of WorkCompCollege.com, talks to the Policy Guys about the diverse and extended course offerings in the realm of workers’ comp available on this innovative training platform. Listen in to boost your understanding as well as your street cred. Read more... |
|
|
May 22, 2024 · Public Policy & Regulatory Affairs Team
Oklahoma expands PTSD coverage for first responders with treatment limits, model drug pricing reporting law amended to exclude work comp and auto, model drug formulary law up for review, Virginia requires patient counseling with opioid prescribing, and several states reviewing changes to their medical rules. Read more... |
|
|
May 16, 2024 · Public Policy & Regulatory Affairs Team
As a result of DEA plans to reclassify marijuana from a Schedule I to a Schedule III drug, more states may decide to reimburse injured workers for its prescribed use and include it in their workers’ comp fee schedules. Clients are advised to follow future developments of this initiative on the federal and state level. Read more... |
|
May 07, 2024 · Clinical Team
On May 4, 2024, the U.S. Food and Drug Administration (FDA) reported that Breckenridge Pharmaceutical, Inc (Breckenridge) issued a retail level recall of duloxetine delayed-release capsules. Read more... |
|
|
May 01, 2024 · Public Policy & Regulatory Affairs Team
California updates work comp opioid guidelines; Kentucky expands the definition for “physician” in work comp; Wisconsin work comp fee schedule bills fail; Pennsylvania continues to deliberate AWP issue; Louisiana Legislature considers work comp. fee schedules; Texas clarifies pharmacy first fill and reviews work comp. reimbursement rules; Alabama wants to add a Parkinson’s disability benefit presumption for firefighters. Read more... |
Page 5 of 5